Epsilon Healthcare (ASX:EPN) - Stock Price, News & Analysis

EPN Stock Overview

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. More details

EPN fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Risk Analysis

Earnings have declined by 4.2% per year over past 5 years

Does not have a meaningful market cap (A$7M)

Shares are highly illiquid

Has less than 1 year of cash runway

+ 1 more risk

Epsilon Healthcare Limited Competitors

Cann Global

ASX:CGB

AU$5.4m

Avecho Biotechnology

ASX:AVE

AU$9.5m

Emyria

ASX:EMD

AU$13.3m

Ecofibre

ASX:EOF

AU$15.4m

Price History & Performance

Summary of all time highs, changes and price drops for Epsilon Healthcare
Historical stock prices
Current Share Price	AU$0.024
52 Week High	AU$0.034
52 Week Low	AU$0.016
Beta	0.92
11 Month Change	0%
3 Month Change	0%
1 Year Change	20.00%
33 Year Change	-89.57%
5 Year Change	-95.60%
Change since IPO	-94.07%

Recent updates

Shareholder Returns

	EPN	AU Pharmaceuticals	AU Market
7D	0%	7.4%	0.03%
1Y	20.0%	64.1%	15.7%

Return vs Industry: EPN underperformed the Australian Pharmaceuticals industry which returned 61.8% over the past year.

Return vs Market: EPN exceeded the Australian Market which returned 9.6% over the past year.

Price Volatility

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.9%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.1%
10% least volatile stocks in AU Market	3.4%

Stable Share Price: EPN has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EPN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	n/a	Daniel Sanghera	epsilonhealthcare.com.au

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021.

Epsilon Healthcare Limited Fundamentals Summary

How do Epsilon Healthcare's earnings and revenue compare to its market cap?
EPN fundamental statistics
Market cap	AU$7.21m
Earnings (TTM)	-AU$5.93m
Revenue (TTM)	AU$7.21m

1.0x

P/S Ratio

-1.2x

P/E Ratio

Is EPN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EPN income statement (TTM)
Revenue	AU$7.21m
Cost of Revenue	AU$5.09m
Gross Profit	AU$2.12m
Other Expenses	AU$8.05m
Earnings	-AU$5.93m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.02
Gross Margin	29.46%
Net Profit Margin	-82.17%
Debt/Equity Ratio	27.1%

How did EPN perform over the long term?

See historical performance and comparison

EPN Stock Overview

Risk Analysis

Epsilon Healthcare Limited Competitors

ASX:CGB

AU$5.4m

ASX:AVE

AU$9.5m

ASX:EMD

AU$13.3m

ASX:EOF

AU$15.4m

Price History & Performance

Recent News & Updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Recent updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

Shareholder Returns

Price Volatility

About the Company

Epsilon Healthcare Limited Fundamentals Summary

1.0x

-1.2x

Earnings & Revenue